CD164
Basic information
Region (hg38): 6:109366514-109382467
Links
Phenotypes
GenCC
Source:
- autosomal dominant nonsyndromic hearing loss 66 (Limited), mode of inheritance: AD
- autosomal dominant nonsyndromic hearing loss (Supportive), mode of inheritance: AD
- autosomal dominant nonsyndromic hearing loss 66 (Limited), mode of inheritance: Unknown
- autosomal dominant nonsyndromic hearing loss (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Deafness, autosomal dominant 66 | AD | Audiologic/Otolaryngologic | Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development | Audiologic/Otolaryngologic | 26197441 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD164 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 13 | ||||
missense | 27 | 35 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 3 | 4 | |||
non coding | 16 | 23 | 41 | |||
Total | 0 | 0 | 29 | 35 | 26 |
Variants in CD164
This is a list of pathogenic ClinVar variants found in the CD164 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-109368228-A-G | Benign (Jun 22, 2018) | |||
6-109368318-T-A | CD164-related disorder | Likely benign (Jan 14, 2020) | ||
6-109368478-T-C | Benign (Dec 10, 2018) | |||
6-109368531-G-C | Likely benign (Aug 04, 2020) | |||
6-109368699-C-T | Benign (Dec 12, 2018) | |||
6-109368704-G-T | Benign (Nov 10, 2018) | |||
6-109368842-T-G | not specified | Uncertain significance (May 15, 2024) | ||
6-109368854-C-T | Likely benign (Aug 04, 2023) | |||
6-109368870-C-T | not specified • CD164-related disorder | Likely benign (Oct 26, 2024) | ||
6-109368871-G-A | Autosomal dominant nonsyndromic hearing loss 66 | no classifications from unflagged records (Apr 25, 2024) | ||
6-109368874-C-T | not specified | Uncertain significance (Sep 13, 2023) | ||
6-109368882-T-C | Uncertain significance (Sep 19, 2024) | |||
6-109368888-A-T | not specified | Uncertain significance (Dec 28, 2022) | ||
6-109368896-A-C | Likely benign (Jun 29, 2022) | |||
6-109368897-A-G | not specified | Uncertain significance (Oct 26, 2024) | ||
6-109368904-A-G | not specified | Uncertain significance (Jan 24, 2024) | ||
6-109368991-T-C | not specified | Uncertain significance (Jun 26, 2024) | ||
6-109368995-A-C | Likely benign (May 11, 2023) | |||
6-109369029-G-C | Benign (Sep 16, 2024) | |||
6-109369314-G-A | Likely benign (Dec 12, 2018) | |||
6-109370125-T-C | Benign (Dec 12, 2018) | |||
6-109370351-G-GTA | Likely benign (Jun 14, 2018) | |||
6-109370395-A-G | Likely benign (Aug 09, 2022) | |||
6-109370418-A-C | Likely benign (Aug 17, 2023) | |||
6-109370420-T-G | not specified | Uncertain significance (Aug 12, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CD164 | protein_coding | protein_coding | ENST00000310786 | 6 | 16046 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.489 | 0.507 | 124558 | 0 | 1 | 124559 | 0.00000401 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.257 | 106 | 98.8 | 1.07 | 0.00000489 | 1226 |
Missense in Polyphen | 60 | 60.489 | 0.99191 | 750 | ||
Synonymous | -0.361 | 42 | 39.1 | 1.07 | 0.00000204 | 406 |
Loss of Function | 2.39 | 2 | 10.3 | 0.195 | 5.85e-7 | 112 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000546 | 0.0000546 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.0000546 | 0.0000546 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Sialomucin that may play a key role in hematopoiesis by facilitating the adhesion of CD34(+) cells to the stroma and by negatively regulating CD34(+)CD38(lo/-) cell proliferation. Modulates the migration of umbilical cord blood CD133+ cells and this is mediated through the CXCL12/CXCR4 axis. May play an important role in prostate cancer metastasis and the infiltration of bone marrow by cancer cells. Promotes myogenesis by enhancing CXCR4-dependent cell motility. Positively regulates myoblast migration and promotes myoblast fusion into myotubes (By similarity). {ECO:0000250|UniProtKB:Q9R0L9, ECO:0000269|PubMed:16859559, ECO:0000269|PubMed:17077324, ECO:0000269|PubMed:9763543}.;
- Disease
- DISEASE: Deafness, autosomal dominant, 66 (DFNA66) [MIM:616969]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:26197441}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Lysosome - Homo sapiens (human);miR-targeted genes in epithelium - TarBase;miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase
(Consensus)
Recessive Scores
- pRec
- 0.115
Intolerance Scores
- loftool
- 0.423
- rvis_EVS
- -0.1
- rvis_percentile_EVS
- 46.49
Haploinsufficiency Scores
- pHI
- 0.293
- hipred
- N
- hipred_score
- 0.169
- ghis
- 0.518
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.379
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cd164
- Phenotype
Zebrafish Information Network
- Gene name
- cd164
- Affected structure
- whole organism
- Phenotype tag
- abnormal
- Phenotype quality
- increased curvature
Gene ontology
- Biological process
- immune response;cell adhesion;heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules;negative regulation of cell adhesion;signal transduction;multicellular organism development;muscle organ development;negative regulation of cell population proliferation;hemopoiesis
- Cellular component
- extracellular region;lysosome;lysosomal membrane;endosome;plasma membrane;integral component of plasma membrane;endosome membrane;cytoplasmic vesicle
- Molecular function
- protein binding